Temozolomide in the management of dopamine agonist-resistant prolactinomas. (Record no. 21581332)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01383 a2200433 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516081412.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201208s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1365-2265 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1111/j.1365-2265.2012.04373.x |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Whitelaw, B C |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20120817 |
| 245 00 - TITLE STATEMENT | |
| Title | Temozolomide in the management of dopamine agonist-resistant prolactinomas. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical endocrinology |
| Date of publication, distribution, etc. | Jun 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 877-86 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Case Reports; Journal Article; Review |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dacarbazine |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dopamine Agonists |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Neoplasm |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prolactinoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Temozolomide |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dworakowska, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thomas, N W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barazi, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Riordan-Eva, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | King, A P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hampton, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Landau, D B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lipscomb, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Buchanan, C R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gilbert, J A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aylwin, S J B |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical endocrinology |
| Related parts | vol. 76 |
| -- | no. 6 |
| -- | p. 877-86 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1111/j.1365-2265.2012.04373.x">https://doi.org/10.1111/j.1365-2265.2012.04373.x</a> |
| Public note | Available from publisher's website |
No items available.